ClinicalTrials.gov · NCT07707778 · Enrolling by invitation
Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV
Registry record
NCT07707778 on ClinicalTrials.gov. The registry's last update to this record was 20 July 2026.
Verification record
5 checked · 0 company says · 0 reported · 0 not found · 0 not yet checked
- Title as registered Tirzepatide's Effects on Epigenetic Aging and Metabolic Restoration in Virally Suppressed People With HIV Checked Source clinicaltrials.gov Brief title as registered. Checked
- Sponsor National Taiwan University Clinical Trial Center Checked Source clinicaltrials.gov Lead sponsor as registered. Checked
- Intervention Tirzepatide Checked Source clinicaltrials.gov Intervention names as registered. Checked
- Primary outcome as registered Second generation epigenetic aging clock | Third generation epigenetic aging clock Checked Source clinicaltrials.gov Primary outcome measure(s) as registered. Checked
- Status Enrolling by invitation Checked Source clinicaltrials.gov Overall status as registered; registry last update 2026-07-20. Checked
Check history: NCT07707778 was last read on the registry on November 14, 2026. No earlier checks are recorded. How records are checked.
Corrections: none recorded for this trial. To ask for one, write to [email protected] with the registry number; every correction is checked against the registry record before the record changes.
As registered
- Sponsor: National Taiwan University Clinical Trial Center
- Phase: Phase 4
- Status: Enrolling by invitation
- Intervention: Tirzepatide
- Primary outcome: Second generation epigenetic aging clock | Third generation epigenetic aging clock
- Countries: Taiwan
- Start: 25 June 2026
- Completion (estimated): December 2027
Results
No results were posted on the registry on the date checked. The Atlas does not summarize findings.